This real-estate company which has a rich legacy of over 5 decades in the construction industry in India and abroad in diverse areas of infrastructure development has bagged large orders worth 832.40 Cr from Max Super Specialty Hospital.
At 12:20 p.m the shares of Ahluwalia Contracts (India) were trading at Rs 720 and with a market capitalisation of 4,803 Cr.
According to the company’s exchange filing on BSE, the company has received orders for construction and expansion of Max Super Specialty Hospital at Mohali, Punjab and Gurugram, Haryana on EPC(Engineering Procurement and Construction) basis for a sum of 215.46 Cr and 616.95 Cr. summing up to 832.40 Cr. The total order inflow of the company for FY 23-24 stands at 5259.50 Cr till date.
The company’s revenue has increased by 5 percent from 2,692 Cr in FY22 to 2838.39 Cr in FY23, accompanied by profits of 155.22 Cr to 193.98 Cr.
The company has reported a return on equity (ROE) of 17.14 percent and return on capital employed (ROCE) of 26 percent, this indicates that the company is able to get good returns on its equity and efficient use of its resources.
According to the latest shareholding data available for the June 2023 quarter, the company’s Promoters hold 55.32 percent stake, the Domestic Institutional Investors hold 27.39 percent and the Foreign Institutional Investors (FII) hold 11.75 percent.
Ahluwalia Contracts (India) is a construction/Real estate company engaged in engineering and contract construction, delivering state of-the-art infrastructure and building projects for its clients in India and abroad.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
